Koyfin Home > Directory > Health Care > Abeona Therapeutics > EBITDA Margin

Abeona Therapeutics EBITDA Margin Chart (ABEO)

Abeona Therapeutics annual/quarterly EBITDA Margin from 2010 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Abeona Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-3,448m a 42.60% decrease of -1,469m year over year
  • Abeona Therapeutics EBITDA Margin for the last 12 months ending September 09, 2019 was $-14,845m a 87.46% decrease of -12,983m year over year
  • Abeona Therapeutics Annual EBITDA Margin for 2018 was $-1,861m a -73.91% increase of 1,376m from 2017
  • Abeona Therapeutics Annual EBITDA Margin for 2017 was $-3,237m a 19.88% decrease of -644m from 2016
  • Abeona Therapeutics Annual EBITDA Margin for 2016 was $-2,593m a 33.28% decrease of -863m from 2015
Other Margins & Efficiency Metrics:
  • Abeona Therapeutics Return on Capital % for the quarter ending September 09, 2018 was -27.18 a 38.09% decrease of -10.35 year over year
  • Abeona Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -42.21 a 38.40% decrease of -16.21 year over year
View Chart On Koyfin

Quarterly ABEO EBITDA Margin Data

12/2018$-3,448m
09/2018$-960m
06/2018$-4,445m
03/2018$-1,979m
12/2017$-4,002m
09/2017$-2,385m
06/2017$-3,794m
03/2017$-2,706m
12/2016$-2,181m
09/2016$-2,691m

Annual ABEO EBITDA Margin Data

2018$-1,861m
2017$-3,237m
2016$-2,593m
2015$-1,730m
2014$-337m
2013$-186m
2012$-88m
2011$-416m
2010$-1,563m